|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/00 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K 16/28 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K2317/35 | (2013.01) | ||
| C07K2317/53 | (2013.01) | ||
| C07K2317/60 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K2319/70 | (2013.01) |
| (11) | Number of the document | 3723791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18829780.8 |
| Date of filing the European patent application | 2018-12-14 | |
| (97) | Date of publication of the European application | 2020-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/084894 |
| Date | 2018-12-14 |
| (87) | Number | WO 2019/115745 |
| Date | 2019-06-20 |
| (30) | Number | Date | Country code |
| 201762598592 P | 2017-12-14 | US | |
| 18168448 | 2018-04-20 | EP |
| (72) |
SPIRIG, Rolf , CH
BAZ MORELLI, Adriana , AU
VERKMAN, Alan , US
TRADTRANTIP, Lukmanee , US
|
| (73) |
CSL Behring Lengnau AG ,
Biotech Innovation Park, 2543 Lengnau BE,
CH
The Regents of the University of California , 1111 Franklin Street, 12th Floor, Oakland, CA 94607, US |
| (54) | RECOMBINANT IGG FC MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA |
| RECOMBINANT IGG FC MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA |